Rejected at 1:17 a.m. Nov, 01, 2023 ] by dollajas
Author: sbeerman
Related Note: 1477447177436 2
Rationale for change

Suggestion for answer:
α1 & non-selective β-antagonist

This phrasing seems to be more clear compared to "non-selective α1 & β-antagonist."

Rejection reason

comments

Text Text
Extra
Empty field
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Empty field
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#Bootcamp::Cardiology::26_Hypertension::06_Antihypertensives #AK_Step1_v12::#Textbooks::#Golan_Pharmacology::11_Adrenergic_Pharmacology #AK_Step1_v12::#NinjaNerd::06_Cardiovascular::04_Pharmacology::06_Beta_Blockers_(MOA,_Indications,_AR,_CI) #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#OME::Clinical::04_Organ_Systems::01_Cardiology::01_Hemodynamics::06_Hypertension_Pharmacology #AK_Step1_v12::#UWorld::COMLEX::27131 #AK_Step1_v12::#Textbooks::#Golan_Pharmacology::24_Pharmacology_Of_Cardiac_Rhythm #AK_Step2_v12::#SketchyIM::01_Cardiology::09_Vascular_Disease::05_Aortic_Dissection #AK_Step2_v12::#Subjects::*Pharm_Extra::Autonomic::B-Blockers #AK_Step1_v12::#Bootcamp::Pharmacology::03_Autonomic_System::16_Beta_Adrenergic_Antagonists #AK_Step1_v12::#NBME::16 #AK_Step2_v12::#AMBOSS::QD0uVR #AK_Step1_v12::#AMBOSS::fNak0O #AK_Step1_v12::#FirstAid::05_Pharm::02_Autonomic_Drugs::15_beta-blockers::*B-Antagonists::Nonselective_a1_B_Antagonists::Labetalol #AK_Step2_v12::#B&B::02_Cardio::05_Pharm::01_Cardiovascular_Pharmacology_I #AK_Step2_v12::#AMBOSS #AK_Step2_v12::!Shelf::FM #AK_Step1_v12::#AMBOSS #AK_Step1_v12::#UWorld::Step::19601 #AK_Step1_v12::#Pixorize::03_Pharmacology::06_Cardiovascular_Pharm::10_Class_II_Antiarrhythmics #AK_Other::Only_Step_1&2_Overlap #AK_Step1_v12::#AMBOSS::8paOrl #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#Pixorize::03_Pharmacology::05_Alpha_&_Beta_Blockers::05_Combined_Alpha-Beta_Blockers_(Carvedilol,Labetalol) #AK_Step1_v12::#Bootcamp::Cardiology::26_Hypertension::03_Hypertension_Variants #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::11_Autonomic_Pharmacology_(Adrenergic_Antagonists) #AK_Step1_v12::#Physeo::09_Pharm::16_Autonomic_Pharm::06_Beta_Blockers #AK_Step2_v12::Original_decks::Dorian::fam::uva_questions #AK_Step1_v12::#B&B::06_Cardio::08_Hypertension::03_Antihypertensives_I #AK_Step1_v12::#SketchyPharm::01_Autonomic_Drugs::02_Sympathetic::04_Beta_blockers #AK_Step1_v12::#OME::04_Organ_Systems::01_Cardiology::01_Hemodynamics::06_Hypertension_Pharmacology #AK_Step2_v12::#Resources_by_rotation::FM::uva_questions #AK_Step1_v12::#Pixorize::03_Pharmacology::24_Alpha_&_Beta_Blockers_(New)::06_Dual_Alpha_Beta_Blockers #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step2_v12::#SketchyOBGYN::02_Pregnancy_Complications::01_Maternal_Complications_of_Pregnancy::02_Preeclampsia_and_Hypertensive_Diseases_of_Pregnancy #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::09_Antihypertensive_Drugs